Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabinoid for Appetite and Pain in Systemic Sclerosis
NCT05416697Phase 3Completed
- Sponsor
- Khon Kaen University
- Start
- Nov 2022
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in anorexia nervosa (AN), Malnutrition, arthralgia and 1 more, sponsored by Khon Kaen University. Primary endpoint: Appetite at 4 weeks. Started Nov 2022; status: completed.
02
Conditions
anorexia nervosa (AN)Malnutritionarthralgiasleep disorder
Beyond the preview
Go deeper on NCT05416697.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05416697.